Patient no. | Age (y) | Sex | Disease duration (y) | Disease severity (stage) | Drug therapy (daily dose) | Drug cessation period* (d) |
---|---|---|---|---|---|---|
1 | 16 | F | 3.2 | 5 | Alprazolam (1.6 mg) | 5 |
2 | 54 | M | 5.8 | 4 | Alprazolam (0.8 mg) | 11 |
3 | 39 | M | 6.3 | 4 | Alprazolam (1.2 mg) | 6 |
4 | 37 | M | 4.9 | 5 | — | |
5 | 30 | M | 5.1 | 2 | Alprazolam (1.2 mg) | 3 |
6 | 39 | F | 6.2 | 7 | Alprazolam (2.4 mg) | 3 |
7 | 31 | M | 3.8 | 5 | — | |
8 | 60 | M | 4.4 | 4 | Alprazolam (0.8 mg) | 3 |
9 | 31 | M | 8.4 | 4 | Alprazolam (0.8 mg) | 5 |
↵* Days before 123I-MIBG examination.